Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00476970|
Recruitment Status : Completed
First Posted : May 22, 2007
Last Update Posted : September 21, 2016
The goal of this study is to implement and in a controlled randomised trial test a program to identify and overcome barriers to CRC screening and thus improve CRC screening rates at MGH Chelsea HC.
Our hypothesis is that a bilingual navigator program, enhanced by using trained interpreting staff will improve CRC screening rates at MGH Chelsea HC overall, and decrease disparities between patients with limited English proficiency and English speakers
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer||Behavioral: Patient Navigation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1223 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improving Colorectal Cancer Screening Rates by Lowering Barriers in Low Income and Non-English Speaking Populations: The Chelsea Colorectal Cancer Screening Project|
|Study Start Date :||September 2007|
|Actual Primary Completion Date :||September 2008|
|Actual Study Completion Date :||September 2008|
Experimental: Patient Navigation Intervention
Participants randomized to this arm will receive language-concordant patient navigation in the form of an introductory letter with educational material followed by phone or in-person contact to provide individually tailored interventions.
Behavioral: Patient Navigation
Patient navigators will perform an initial interview with participants to identify and explore barriers, work with patients to overcome barriers, educate patients about CRC screening, motivate and coach patients, and schedule and accompany patients to colonoscopy testing
No Intervention: Usual Care
Participants randomized to this arm will receive no additional navigation beyond the usual care for the duration of the 9-month intervention. Participants will be offered navigation services after the completion of the intervention period.
- Percentage of Eligible Patients In Study and Control Groups Who Undergo CRC Screening [ Time Frame: 18 Months ]
- Type of CRC Screening Test Performed in Study vs Control Groups [ Time Frame: 18 Months ]
- Number of Polyps and Cancers per 100 Patients in the Study vs Control Group [ Time Frame: 18 Months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00476970
|United States, Massachusetts|
|MGH Chelsea Health Center|
|Chelsea, Massachusetts, United States, 02150|
|Principal Investigator:||Sanja Percac-Lima, MD, PhD||Massachusetts General Hospital|